Your browser is no longer supported. Please, upgrade your browser.
Settings
SPPI Spectrum Pharmaceuticals, Inc. daily Stock Chart
SPPI [NASD]
Spectrum Pharmaceuticals, Inc.
Index- P/E- EPS (ttm)-1.33 Insider Own0.20% Shs Outstand113.65M Perf Week-18.24%
Market Cap305.72M Forward P/E- EPS next Y-1.45 Insider Trans-12.84% Shs Float106.33M Perf Month-68.68%
Income-144.40M PEG- EPS next Q-0.33 Inst Own77.30% Short Float10.78% Perf Quarter-65.25%
Sales29.40M P/S10.40 EPS this Y-88.90% Inst Trans0.04% Short Ratio5.01 Perf Half Y-63.25%
Book/sh2.11 P/B1.27 EPS next Y-43.60% ROA-36.10% Target Price9.75 Perf Year-75.18%
Cash/sh2.18 P/C1.23 EPS next 5Y- ROE-47.00% 52W Range2.85 - 12.15 Perf YTD-26.10%
Dividend- P/FCF- EPS past 5Y-2.60% ROI-46.30% 52W High-77.86% Beta2.46
Dividend %- Quick Ratio- Sales past 5Y-6.80% Gross Margin76.70% 52W Low-5.61% ATR0.40
Employees235 Current Ratio5.70 Sales Q/Q- Oper. Margin- RSI (14)19.37 Volatility6.67% 7.07%
OptionableYes Debt/Eq0.00 EPS Q/Q64.00% Profit Margin- Rel Volume1.44 Prev Close2.87
ShortableYes LT Debt/Eq0.00 EarningsFeb 06 AMC Payout- Avg Volume2.29M Price2.69
Recom2.20 SMA20-24.34% SMA50-60.09% SMA200-65.96% Volume3,304,493 Change-6.11%
Dec-26-19Downgrade Guggenheim Buy → Neutral
Dec-26-19Downgrade Cantor Fitzgerald Overweight → Neutral $17 → $4
Nov-27-19Resumed B. Riley FBR Buy $18
Jul-11-19Initiated B. Riley FBR Buy $18
Mar-15-19Resumed Jefferies Buy $21
Nov-12-18Reiterated B. Riley FBR Buy $35 → $29
Dec-18-17Initiated B. Riley FBR, Inc. Buy $26
Oct-24-17Initiated Guggenheim Buy $32
Oct-19-17Reiterated H.C. Wainwright Buy $20 → $29
Oct-04-17Reiterated H.C. Wainwright Buy $14 → $20
Aug-16-17Resumed H.C. Wainwright Buy $14
Feb-10-17Resumed Jefferies Buy
Nov-05-15Reiterated RBC Capital Mkts Outperform $13 → $12
Aug-07-15Reiterated RBC Capital Mkts Outperform $12 → $13
Apr-02-15Initiated FBR Capital Outperform $9
Feb-23-15Downgrade ROTH Capital Buy → Neutral $15 → $7
Jul-15-14Upgrade R. F. Lafferty Sell → Neutral $7.50
Oct-07-13Initiated HC Wainwright Buy $15
May-29-13Initiated Burrill Institutional Research Mkt Outperform $12
Mar-13-13Reiterated RBC Capital Mkts Outperform $19 → $16
Jan-17-20 05:50PM  Spectrum Pharmaceuticals (SPPI) Stock Sinks As Market Gains: What You Should Know Zacks
Jan-15-20 01:39PM  Such Is Life: How Spectrum Pharmaceuticals (NASDAQ:SPPI) Shareholders Saw Their Shares Drop 68% Simply Wall St.
Dec-27-19 02:50PM  Spectrum Pharma Analyst Says Sell-Off May Have Been Overdone Benzinga
08:05AM  Spectrum Pharmaceuticals is Oversold: Can It Recover? Zacks
07:59AM  The Daily Biotech Pulse: Flexion Receives FDA Nod For Zilretta Label Expansion, Astellas Goes Shopping Benzinga
06:56AM  Spectrum Pharmaceuticals shares slide 57% after lung cancer trial misses goals MarketWatch
Dec-26-19 03:57PM  PreMarket Prep Recap: Qiagen Pulls The Rug Out From Investors Banking On A Deal, Bad Data Equals Bad Price Action For Spectrum Pharmaceuticals Benzinga -60.00%
02:09PM  Stocks eye fresh records in thin post-Christmas trade MarketWatch
08:33AM  UPDATE: Spectrum Pharma shares slide 47% premarket after trial of lung cancer treatment misses main goal MarketWatch
07:55AM  The Daily Biotech Pulse: Qiagen Opts To Stay Solo Following Strategic Review, Spectrum Slumps On Negative Data, Microbot Medical To Offer Shares Benzinga
07:00AM  Spectrum Pharmaceuticals Provides Pipeline Update on Late Stage Programs Business Wire
05:57AM  Spectrum Pharma Shares Slump After Lung-Cancer Drug Doesn't Meet Phase II Endpoint TheStreet.com
Dec-17-19 10:01AM  Hedge Funds Are Dumping Spectrum Pharmaceuticals, Inc. (SPPI) Insider Monkey
Dec-11-19 03:27PM  Top stock picks for 2020: Standout small companies MarketWatch
Dec-07-19 11:31AM  Why Is Spectrum Pharma (SPPI) Up 23.9% Since Last Earnings Report? Zacks
Dec-05-19 06:32AM  Will Spectrum Pharmaceuticals Continue to Surge Higher? Zacks
Nov-27-19 08:44AM  Options Traders Expect Huge Moves in Spectrum Pharmaceuticals (SPPI) Stock Zacks
Nov-16-19 09:40PM  Edited Transcript of SPPI earnings conference call or presentation 7-Nov-19 9:30pm GMT Thomson Reuters StreetEvents
Nov-14-19 09:57AM  Spectrum Pharmaceuticals to Present Corporate Update at the Jefferies 2019 London Healthcare Conference on November 21st Business Wire
Nov-08-19 10:08AM  Spectrum Pharma's (SPPI) Q3 Loss Narrows, Focus on Rolontis Zacks +8.56%
Nov-07-19 04:00PM  Spectrum Pharmaceuticals Reports Third Quarter 2019 Financial Results and Pipeline Update Business Wire
Oct-31-19 07:00AM  Spectrum Pharmaceuticals Announces Third Quarter 2019 Financial Results Conference Call Business Wire
Oct-28-19 04:21PM  Heres What Hedge Funds Think About Spectrum Pharmaceuticals, Inc. (SPPI) Insider Monkey
Oct-24-19 04:00PM  Spectrum Pharmaceuticals Announces Submission to the U.S. Food and Drug Administration of Updated Biologics License Application for ROLONTIS® Business Wire
Oct-23-19 11:16AM  Is the Options Market Predicting a Spike in Spectrum Pharma (SPPI) Stock? Zacks
Oct-04-19 07:00AM  Spectrum Pharmaceuticals Announces Publication of Positive Poziotinib Data in Cancer Cell Business Wire
Oct-01-19 02:58PM  We're Hopeful That Spectrum Pharmaceuticals (NASDAQ:SPPI) Will Use Its Cash Wisely Simply Wall St. -6.45%
Sep-27-19 11:03AM  FibroGen Begins Study on Roxadustat for Chemo-Induced Anemia Zacks
Sep-25-19 07:00AM  Spectrum Pharmaceuticals to Present Corporate Update at the 2019 Cantor Global Healthcare Conference on October 2nd Business Wire +6.19%
Sep-20-19 11:54AM  FibroGen's Evrenzo Gets Nod in Japan for Anemia with CKD Zacks -5.29%
Sep-09-19 11:14AM  Will These 2 Falling Knives Bounce Back? GuruFocus.com
Sep-07-19 09:30AM  Spectrum Pharma (SPPI) Down 0.7% Since Last Earnings Report: Can It Rebound? Zacks
Sep-06-19 04:30PM  Spectrum Announces Poziotinib Data Being Presented at the IASLC 2019 World Conference on Lung Cancer Business Wire
Sep-02-19 11:40AM  Edited Transcript of SPPI earnings conference call or presentation 8-Aug-19 8:30pm GMT Thomson Reuters StreetEvents
Aug-16-19 11:31AM  How Much Are Spectrum Pharmaceuticals, Inc. (NASDAQ:SPPI) Insiders Taking Off The Table? Simply Wall St. +7.95%
Aug-12-19 03:03PM  Rockville biopharma to sell first product on market in 28 years but not in the U.S. American City Business Journals
10:47AM  Spectrum Pharma's (SPPI) Loss Narrows in Q2, Stock Rises Zacks
Aug-08-19 10:57PM  Spectrum Pharmaceuticals, Inc. (SPPI) Q2 2019 Earnings Call Transcript Motley Fool
05:25PM  Spectrum Pharmaceuticals (SPPI) Reports Q2 Loss, Misses Revenue Estimates Zacks
04:00PM  Spectrum Pharmaceuticals Reports Second Quarter 2019 Financial Results and Pipeline Update Business Wire
Aug-01-19 10:32AM  Analysts Estimate Spectrum Pharmaceuticals (SPPI) to Report a Decline in Earnings: What to Look Out for Zacks
Jul-22-19 07:00AM  Spectrum Announces Expansion of the Poziotinib Clinical Program Business Wire
Jun-28-19 06:11PM  Heres What Hedge Funds Think About Spectrum Pharmaceuticals, Inc. (SPPI) Insider Monkey
Jun-23-19 04:56PM  The 5 Most Expensive Drugs In US: What You Should Know Benzinga
Jun-20-19 07:00AM  Spectrum Pharmaceuticals Appoints Elizabeth Czerepak to its Board of Directors Business Wire
Jun-17-19 09:54AM  What Kind Of Investor Owns Most Of Spectrum Pharmaceuticals, Inc. (NASDAQ:SPPI)? Simply Wall St. +9.93%
Jun-13-19 09:36AM  Ligand Inks Oncology Drug Discovery Deal With PhoreMost Zacks
Jun-08-19 09:30AM  Why Is Spectrum Pharma (SPPI) Down 14.4% Since Last Earnings Report? Zacks
Jun-02-19 09:02AM  Spectrum Pharmaceuticals Announces Integrated Results from Two Phase 3 ROLONTIS® (eflapegrastim) Trials Being Presented at the ASCO Annual Meeting Business Wire
May-29-19 07:00AM  Spectrum Pharmaceuticals to Present Corporate Update at the Jefferies 2019 Global Healthcare Conference on June 5th Business Wire
May-28-19 07:00AM  Spectrum Announces Poziotinib ZENITH20 Trial HER2 Cohort (Cohort 2) Has Reached Enrollment Target Business Wire
May-21-19 01:33AM  Edited Transcript of SPPI earnings conference call or presentation 9-May-19 8:30pm GMT Thomson Reuters StreetEvents +5.97%
May-16-19 07:00AM  Spectrum Pharmaceuticals to Present Corporate Update at the 20th Annual B. Riley FBR Investor Conference on May 23rd Business Wire
May-10-19 05:55PM  Spectrum Pharmaceuticals, Inc. (SPPI) Q1 2019 Earnings Call Transcript Motley Fool
10:11AM  Spectrum Pharma (SPPI) Q1 Earnings Lag Estimates, Revenues Nil Zacks
05:05AM  Spectrum Pharma: 1Q Earnings Snapshot Associated Press
May-09-19 04:00PM  Spectrum Pharmaceuticals Reports First Quarter 2019 Financial Results and Pipeline Update Business Wire
07:00AM  Spectrum Announces Asset Purchase and License for a Novel Immuno-Oncology Platform including Two Early Stage Assets Business Wire
May-07-19 10:56AM  Is Spectrum Pharmaceuticals, Inc. (SPPI) A Good Stock To Buy? Insider Monkey -6.05%
May-02-19 07:00AM  Spectrum Pharmaceuticals Announces First Quarter 2019 Financial Results Conference Call Business Wire
Apr-25-19 10:33AM  Analysts Estimate Spectrum Pharmaceuticals (SPPI) to Report a Decline in Earnings: What to Look Out for Zacks
Apr-09-19 12:07PM  The Spectrum Pharmaceuticals (NASDAQ:SPPI) Share Price Has Gained 66% And Shareholders Are Hoping For More Simply Wall St. -8.06%
Apr-02-19 07:00AM  Spectrum Pharmaceuticals to Present Corporate Update at the H.C. Wainwright Global Life Sciences Conference on April 9 Business Wire
Mar-30-19 09:30AM  Why Is Spectrum Pharma (SPPI) Down 1.1% Since Last Earnings Report? Zacks
Mar-25-19 07:10AM  Report: Exploring Fundamental Drivers Behind ON Semiconductor, Pilgrim's Pride, Merck & Co., Healthcare Services Group, Genomic Health, and Spectrum Pharmaceuticals New Horizons, Emerging Trends, and Upcoming Developments GlobeNewswire
Mar-18-19 09:22AM  Spectrum Pharma (SPPI) Withdraws Rolontis BLA, Shares Down Zacks
Mar-15-19 07:23AM  Spectrum Pharma withdraws license application for Rolontis after FDA seeks information on manufacturing MarketWatch
07:00AM  Spectrum Pharmaceuticals Provides BLA Filing Update for ROLONTIS® (eflapegrastim) Business Wire
Mar-13-19 07:00AM  Spectrum Pharmaceuticals to Present Corporate Update at the Oppenheimer 29th Annual Healthcare Conference on March 20 Business Wire
Mar-06-19 09:05AM  Ligand Sells Promacta Rights for $827M, Updates '19 View Zacks -6.14%
Mar-05-19 04:09PM  Edited Transcript of SPPI earnings conference call or presentation 28-Feb-19 9:30pm GMT Thomson Reuters StreetEvents
Mar-01-19 05:28PM  Spectrum Pharmaceuticals Announces the Completion of the Sale of its Marketed Portfolio Business Wire
09:33AM  Spectrum (SPPI) Misses Earnings Estimates in Q4, Tops Sales Zacks
Feb-28-19 06:30PM  Spectrum Pharmaceuticals Inc (SPPI) Q4 2018 Earnings Conference Call Transcript Motley Fool
04:00PM  Spectrum Pharmaceuticals Reports Fourth Quarter 2018 and Full Year 2018 Financial Results and Pipeline Update Business Wire
Feb-21-19 01:38PM  Read This Before Buying Spectrum Pharmaceuticals, Inc. (NASDAQ:SPPI) Shares Simply Wall St.
07:00AM  Spectrum Pharmaceuticals Announces Fourth Quarter and Full Year 2018 Financial Results Conference Call Business Wire
Feb-07-19 07:00AM  Spectrum Pharmaceuticals to Present Corporate Update at the Guggenheim Healthcare Talks Idea Forum on February 14 Business Wire
12:50AM  Top 4 Small-Cap Stocks for 2018 Investopedia
Jan-17-19 08:25AM  Spectrum Pharma Sells Marketed Portfolio in a Deal That Could Reach $300 Million TheStreet.com
07:56AM  Spectrum Pharma sells marketed portfolio for $160 million upfront, up to $140 million in milestone payments MarketWatch
07:45AM  Spectrum Pharmaceuticals Sells Marketed Portfolio to Acrotech Biopharma L.L.C. to Focus on New and Innovative Therapies for Cancer Patients Business Wire
Jan-03-19 10:29AM  Spectrum Pharma Fully Enrolls 1St Cohort in Poziotinib Study Zacks
Jan-02-19 07:00AM  Spectrum Pharmaceuticals Announces Full Enrollment of the Poziotinib EGFR Cohort for Previously Treated Non-Small Cell Lung Cancer Patients with Exon 20 Insertion Mutations Business Wire +5.49%
Dec-28-18 09:45AM  Spectrum Pharma Files BLA for Neutropenia Candidate Rolontis Zacks
Dec-27-18 04:37PM  Why J.C. Penney, Tesla, and Spectrum Pharmaceuticals Slumped Today Motley Fool -6.53%
02:54PM  Here's Why Spectrum Pharmaceuticals Fell as Much as 13.1% Today Motley Fool
07:00AM  Spectrum Pharmaceuticals Announces Submission of Biologics License Application to the FDA for ROLONTIS® (eflapegrastim) as a Treatment for Chemotherapy-Induced Neutropenia Business Wire
Dec-20-18 04:07PM  Here's Why Spectrum Pharmaceuticals, Inc. Is Getting Beaten Down Today Motley Fool -38.79%
10:52AM  Spectrum Pharma Shares Plunge As FDA Refuses Breakthrough Designation For Lung Cancer Drug Benzinga
07:53AM  The Daily Biotech Pulse: Tilray Inks Cannabis Drink Pact, Double Delight For Merck, FDA Snub For Spectrum Benzinga
07:00AM  Today's Research Reports on Trending Tickers: Spectrum Pharmaceuticals and MannKind ACCESSWIRE
Dec-19-18 05:09PM  Stocks making the biggest moves after hours: Tilray, Spectrum Pharmaceuticals and more CNBC
04:28PM  Spectrum Pharma stock tanks after drug fails to get on speedier track MarketWatch
04:00PM  Spectrum Pharmaceuticals Provides Poziotinib Update Business Wire
Dec-18-18 10:43AM  Spectrum Pharmaceuticals, Inc. (NASDAQ:SPPI): When Will It Breakeven? Simply Wall St.
Dec-12-18 11:41PM  Is Spectrum Pharmaceuticals, Inc. (SPPI) Going to Burn These Hedge Funds? Insider Monkey
Dec-10-18 09:00PM  Here's Why Spectrum Pharmaceuticals Rose 21.5% in November Motley Fool
Dec-08-18 09:30AM  Spectrum Pharma (SPPI) Down 3.7% Since Last Earnings Report: Can It Rebound? Zacks
Dec-06-18 04:18PM  Edited Transcript of SPPI earnings conference call or presentation 8-Nov-18 9:30pm GMT Thomson Reuters StreetEvents
Spectrum Pharmaceuticals, Inc. develops and commercializes oncology and hematology drug products. The company offers KHAPZORY, a novel folate analog and the pharmacologically active levo-isomer of d, and 1-leucovorin; FOLOTYN, a folate analogue metabolic inhibitor for peripheral T-cell lymphoma (PTCL); ZEVALIN injection to treat non-Hodgkin's lymphoma; MARQIBO for adult patients with Philadelphia chromosome-negative acute lymphoblastic leukemia; BELEODAQ, a histone deacytelase, or HDAC, inhibitor for the treatment of patients with relapsed or refractory PTCL; and EVOMELA for use as a conditioning treatment prior to autologous stem cell transplant in multiple myeloma patients. It is also developing POZIOTINIB, a pan-HER inhibitor for non-small cell lung cancer tumors; ROLONTIS for chemotherapy-induced neutropenia; and QAPZOLA for non-muscle invasive bladder cancer. The company sells its drugs through group purchasing organizations, wholesalers, and directly to hospitals and cancer centers in the United States; and through distributors in Europe. It has a strategic partnership with Servier Canada, Inc.; licensing and development agreement with Cell Therapeutics, Inc.; license agreements with Merck & Cie AG, Medac Pharma, Inc., Sloan-Kettering Institute for Cancer Research, SRI International, Southern Research Institute, Medac Pharma, Inc., Cydex Pharmaceuticals, Inc., and Mundipharma International Corporation Limited; development and commercialization collaboration agreement with Allergan, Inc.; collaboration agreement with Nippon Kayaku Co., LTD.; licensing and collaboration agreement with Onxeo DK; and co-development and commercialization agreements with Hanmi Pharmaceutical Co. Ltd and The University of Texas MD Anderson Cancer Center. The company was formerly known as NeoTherapeutics, Inc. and changed its name to Spectrum Pharmaceuticals, Inc. in December 2002. Spectrum Pharmaceuticals, Inc. was founded in 1987 and is headquartered in Henderson, Nevada.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
GUSTAFSON KURT AEVP & Chief Financial OfficerJan 17Sale3.331,6215,398231,955Jan 17 06:24 PM
Turgeon Joseph W.CEO & PresidentJan 17Sale3.331,9446,474425,280Jan 17 06:14 PM
Riga Thomas JEVP, COO & CCOJan 17Sale3.265,00016,301241,678Jan 17 06:12 PM
GUSTAFSON KURT AEVP & Chief Financial OfficerJan 16Sale3.372,5228,492233,576Jan 17 06:24 PM
Turgeon Joseph W.CEO & PresidentJan 16Sale3.373,75312,636427,224Jan 17 06:14 PM
Riga Thomas JEVP, COO & CCOJan 16Sale3.3711,38138,320246,678Jan 17 06:12 PM
LEBEL FRANCOISChief Medical OfficerNov 06Sale8.166,96356,825113,970Nov 08 04:01 PM
McGahan Keith MChief Legal OfficerAug 12Sale7.772942,283135,543Aug 12 06:52 PM
Ashton WilliamDirectorJun 20Sale8.501,66714,1706,666Jun 21 08:02 PM
Ashton WilliamDirectorJun 19Sale8.595,00042,9508,333Jun 21 08:02 PM
McGahan Keith MChief Legal OfficerJun 19Sale8.493,53530,002135,756Jun 21 07:39 PM
Turgeon Joseph W.CEO & PresidentJun 06Sale7.9518,240145,070430,977Jun 10 08:11 PM
MAIDA ANTHONY E IIIDirectorMay 29Option Exercise6.0950,000304,50072,250May 31 09:33 AM
MAIDA ANTHONY E IIIDirectorMay 29Sale7.7542,643330,35529,607May 31 09:33 AM
Krassner Stuart MitchellDirectorMay 28Option Exercise6.0944,929273,618112,873May 29 05:00 PM
Krassner Stuart MitchellDirectorMay 28Sale8.0037,385299,08075,488May 29 05:00 PM
Krassner Stuart MitchellDirectorMay 24Option Exercise6.095,07130,88273,015May 29 05:00 PM
Krassner Stuart MitchellDirectorMay 24Sale7.945,07140,26467,944May 29 05:00 PM
Turgeon Joseph W.CEO & PresidentMay 16Sale8.5322,702193,755449,217May 17 06:13 PM
Riga Thomas JEVP, COO & CCOMay 14Sale8.822,38821,069258,035May 14 05:58 PM
McGahan Keith MSVP and Chief Legal OfficerMay 14Sale8.824584,041139,291May 14 05:50 PM
McGahan Keith MSVP and Chief Legal OfficerApr 11Sale10.672,01821,532139,749Apr 12 06:17 PM
MAIDA ANTHONY E IIIDirectorApr 11Sale10.6710,738114,57422,250Apr 12 06:01 PM
Riga Thomas JEVP, COO & CCOApr 11Sale10.7516,493177,341260,423Apr 12 06:40 PM
McGahan Keith MSVP and Chief Legal OfficerApr 02Sale10.571,81019,126141,767Apr 03 06:48 PM
Riga Thomas JEVP, COO & CCOApr 02Sale10.571,88219,887276,988Apr 03 06:47 PM
GUSTAFSON KURT AEVP & Chief Financial OfficerApr 01Sale10.764,64249,940236,098Apr 01 06:14 PM
GUSTAFSON KURT AEVP & Chief Financial OfficerMar 29Sale10.655,97463,623240,740Apr 01 06:14 PM
Turgeon Joseph W.CEO & PresidentMar 29Sale10.656,30767,170471,919Mar 29 06:50 PM
GUSTAFSON KURT AEVP & Chief Financial OfficerMar 26Sale9.909269,167246,714Mar 27 06:35 PM
GUSTAFSON KURT AEVP & Chief Financial OfficerMar 25Sale9.463,79735,931247,640Mar 25 05:51 PM
Turgeon Joseph W.CEO & PresidentMar 25Sale9.465,31550,296478,226Mar 25 05:50 PM
MAIDA ANTHONY E IIIDirectorMar 21Option Exercise5.055,50027,77538,488Mar 22 07:54 PM
MAIDA ANTHONY E IIIDirectorMar 21Sale10.005,50055,00032,988Mar 22 07:54 PM
MAIDA ANTHONY E IIIDirectorFeb 21Option Exercise5.055,50027,77538,488Feb 22 04:31 PM
MAIDA ANTHONY E IIIDirectorFeb 21Sale11.635,50063,96532,988Feb 22 04:31 PM
Riga Thomas JEVP, COO & CCOFeb 20Sale11.472,28526,218278,808Feb 20 05:38 PM
McGahan Keith MSVP and Chief Legal OfficerFeb 07Sale11.032,49627,541103,577Feb 08 05:28 PM